81 related articles for article (PubMed ID: 38629410)
41. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis.
Otrock ZK; Eby CS
Am J Hematol; 2015 Mar; 90(3):220-4. PubMed ID: 25469675
[TBL] [Abstract][Full Text] [Related]
42. Hemophagocytic syndromes--an update.
Janka GE; Lehmberg K
Blood Rev; 2014 Jul; 28(4):135-42. PubMed ID: 24792320
[TBL] [Abstract][Full Text] [Related]
43. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis.
Parikh SA; Kapoor P; Letendre L; Kumar S; Wolanskyj AP
Mayo Clin Proc; 2014 Apr; 89(4):484-92. PubMed ID: 24581757
[TBL] [Abstract][Full Text] [Related]
44. Adult haemophagocytic syndrome.
Ramos-Casals M; Brito-Zerón P; López-Guillermo A; Khamashta MA; Bosch X
Lancet; 2014 Apr; 383(9927):1503-1516. PubMed ID: 24290661
[TBL] [Abstract][Full Text] [Related]
45. Hemophagocytic lymphohistiocytosis: advances in pathophysiology, diagnosis, and treatment.
Chandrakasan S; Filipovich AH
J Pediatr; 2013 Nov; 163(5):1253-9. PubMed ID: 23953723
[No Abstract] [Full Text] [Related]
46. Elevated Granzyme B in Cytotoxic Lymphocytes is a Signature of Immune Activation in Hemophagocytic Lymphohistiocytosis.
Mellor-Heineke S; Villanueva J; Jordan MB; Marsh R; Zhang K; Bleesing JJ; Filipovich AH; Risma KA
Front Immunol; 2013; 4():72. PubMed ID: 23524976
[TBL] [Abstract][Full Text] [Related]
47. Flow cytometric findings in hemophagocytic lymphohistiocytosis.
McCall CM; Mudali S; Arceci RJ; Small D; Fuller S; Gocke CD; Vuica-Ross M; Burns KH; Borowitz MJ; Duffield AS
Am J Clin Pathol; 2012 May; 137(5):786-94. PubMed ID: 22523218
[TBL] [Abstract][Full Text] [Related]
48. Familial and acquired hemophagocytic lymphohistiocytosis.
Janka GE
Annu Rev Med; 2012; 63():233-46. PubMed ID: 22248322
[TBL] [Abstract][Full Text] [Related]
49. Approach to hemophagocytic syndromes.
Weitzman S
Hematology Am Soc Hematol Educ Program; 2011; 2011():178-83. PubMed ID: 22160031
[TBL] [Abstract][Full Text] [Related]
50. A killer on the road: circulating CD4(+)CD28null T cells as cardiovascular risk factor in ESRD patients.
Betjes MG; Meijers RW; de Wit LE; Litjens NH
J Nephrol; 2012; 25(2):183-91. PubMed ID: 22135034
[TBL] [Abstract][Full Text] [Related]
51. Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management.
Gholam C; Grigoriadou S; Gilmour KC; Gaspar HB
Clin Exp Immunol; 2011 Mar; 163(3):271-83. PubMed ID: 21303357
[TBL] [Abstract][Full Text] [Related]
52. The structural basis for membrane binding and pore formation by lymphocyte perforin.
Law RH; Lukoyanova N; Voskoboinik I; Caradoc-Davies TT; Baran K; Dunstone MA; D'Angelo ME; Orlova EV; Coulibaly F; Verschoor S; Browne KA; Ciccone A; Kuiper MJ; Bird PI; Trapani JA; Saibil HR; Whisstock JC
Nature; 2010 Nov; 468(7322):447-51. PubMed ID: 21037563
[TBL] [Abstract][Full Text] [Related]
53. Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases.
Rohr J; Beutel K; Maul-Pavicic A; Vraetz T; Thiel J; Warnatz K; Bondzio I; Gross-Wieltsch U; Schündeln M; Schütz B; Woessmann W; Groll AH; Strahm B; Pagel J; Speckmann C; Janka G; Griffiths G; Schwarz K; zur Stadt U; Ehl S
Haematologica; 2010 Dec; 95(12):2080-7. PubMed ID: 20823128
[TBL] [Abstract][Full Text] [Related]
54. Perforin: structure, function, and role in human immunopathology.
Voskoboinik I; Dunstone MA; Baran K; Whisstock JC; Trapani JA
Immunol Rev; 2010 May; 235(1):35-54. PubMed ID: 20536554
[TBL] [Abstract][Full Text] [Related]
55. Familial and acquired hemophagocytic lymphohistiocytosis.
Janka GE
Eur J Pediatr; 2007 Feb; 166(2):95-109. PubMed ID: 17151879
[TBL] [Abstract][Full Text] [Related]
56. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.
Henter JI; Horne A; Aricó M; Egeler RM; Filipovich AH; Imashuku S; Ladisch S; McClain K; Webb D; Winiarski J; Janka G
Pediatr Blood Cancer; 2007 Feb; 48(2):124-31. PubMed ID: 16937360
[TBL] [Abstract][Full Text] [Related]
57. Review of hemophagocytic lymphohistiocytosis (HLH) in children with focus on Japanese experiences.
Ishii E; Ohga S; Imashuku S; Kimura N; Ueda I; Morimoto A; Yamamoto K; Yasukawa M
Crit Rev Oncol Hematol; 2005 Mar; 53(3):209-23. PubMed ID: 15718147
[TBL] [Abstract][Full Text] [Related]
58. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.
Jordan MB; Hildeman D; Kappler J; Marrack P
Blood; 2004 Aug; 104(3):735-43. PubMed ID: 15069016
[TBL] [Abstract][Full Text] [Related]
59. T-cell lymphoma of CD3+CD4+CD56+granular lymphocytes with hemophagocytic syndrome.
Noguchi M; Kawano Y; Sato N; Oshimi K
Leuk Lymphoma; 1997 Jul; 26(3-4):349-58. PubMed ID: 9322898
[TBL] [Abstract][Full Text] [Related]
60. Aggressive pleomorphic CD2+, CD3-, CD56+ lymphoma with t(5;9)(q31;q34) abnormality.
Wong KF; Chan JK; Ma SK; Lai KY
Cancer Genet Cytogenet; 1995 Jul; 82(1):73-5. PubMed ID: 7543014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]